You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Effect of native fucoidan, sulfated fucoidan, heparin and 6-aminohexanoic acid on the activation of glutamic-plasminogen by urokinase: role of NaCl

Hall, Gustavia; Lang, Deshawn; Qiu, Xiangdong; Doctor, Vasant

Blood Coagulation & Fibrinolysis:
doi: 10.1097/01.mbc.0000224847.12131.89
Original Articles

Addition of a physiological concentration of NaCl (0.9%) to 0.05 mol/l Tris buffer (pH 7.4) reversed the enhancement of the activation of glutamic-type plasminogen (Glu-Plg) by low molecular weight urokinase by fucoidan and heparin, while addition of aminohexanoic acid (6-AH) enhanced the activation. Native fucoidan (N-2), sulfated fucoidan (S-2) and heparin alone and in the presence of 6-AH were investigated to determine the effect of NaCl addition to 0.05 mol/l Tris (pH 7.4) on the activation of Glu-plg by high molecular weight urokinase (HMW u-Pa). Heparin alone and in conjunction with 6-AH enhanced 4.5 to 5.5-fold the initial rate of activation of Glu-plg, while N-2 alone or in conjunction with 6-AH gave 3 to 5.5-fold enhancement and S-2 gave no enhancement of activation using 0.05 mol/l Tris buffer (pH 7.4). Addition of 0.9% NaCl to the buffer reversed the enhancement by the cofactors but, in the presence of 6-AH, N-2 gave two-fold and S-2 gave three-fold enhancement of activation while heparin gave 25% enhancement. The mechanism of enhancement by S-2 in the presence of 6-AH was investigated by dilution and enzyme kinetic studies. The results show that the enhancement was due to interaction with HMW u-PA and not with Glu-plg.

Author Information

Department of Chemistry, Prairie View A&M University, Prairie View, Texas, USA

Received 15 August, 2005

Revised 18 December, 2005

Accepted 14 February, 2006

Correspondence and request for reprints to Vasant Doctor, Department of Chemistry, Prairie View A&M University, P.O.Box 4107, Prairie View, TX 77446, USA Tel: +1 936 857 2617; fax: +1 936 857 2546; e-mail:

Sponsorship: This study was supported by Grant No. 08094 from NIGMS-NIH.

© 2006 Lippincott Williams & Wilkins, Inc.